A European team aims to streamline a new platform that will combine cutting-edge sequencing and informatics technology to combat drug-resistant pathogens.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
Matthew Dublin is a senior writer at Genome Technology.